Areas of Focus
- Tumor Metabolism and Tumor Immunity
Work Experience
- 2021.4-present - Fudan University - Associate Research Fellow
- 2020.7-2021.3 - ShanghaiTech University - Assistant Researcher
- 2017.12-2020.6 - ShanghaiTech University - Postdoctoral Researcher
Academic Background & Achievements
- 2011.9-2017.6 Ph.D. in Science (Cell Biology): Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
- 2007.9-2011.6 B.Sc. in Life Sciences: Nankai University
Publications
- Potentiating the anti-tumor response of tumor infiltrated T cells by NAD+ supplementation, Wang Y*, Wang F*, Wang L*, Qiu S*, Yao Y, Yan C, Xiong X, Chen Y, Ji Q, Cao J, Li D, Zhang L, Guo L, Wang R, Wang H, Fan G, 2021
- Synthetic lethality by targeting HSPA1A in ARID2-deficient lung cancer, Wang X*, Wang Y*, Fang Z*, Wang H, Zhang J, Zhang L, Huang H, Jiang Z, Jin Y, Han X, Hou S, Zhou B, Meng F, Chen L, Wong K, Liu J, Zhang Z, Zhang Z, Chen H, Sun Y, Ji H, 2021
- Drug tolerance and resistance regulated by epigenetic memory through branched-chain amino acid metabolic reprogramming, Wang Y*, Zhang J, Ren S, Sun D, Huang HY, Wang H, Jin Y, Li F, Zheng C, Yang L, Deng L, Jiang Z, Jiang T, Han X, Hou S, Guo C, Li F, Gao D, Qin J, Gao D, Chen L, Lin SH, Wong KK, Li C, Zhou C, Ji H, 2019
- Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin, Wang Y*, Cao J*, Liu W*, Zhang J, Wang Z, Zhang Y, Hou L, Chen S, Hao P, Zhang L, Zhuang M, Yu Y, Li D, Fan G, 2019
- Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis, Zheng C*, Wang Y*, Yang L, Zhou S, Gao Y, Li F, Feng Y, Wang Z, Zhan L, Yan Q, Zhu X, Wong KK, Chen Z, Ji H, 2017
- Personalized characterization of diseases using sample-specific networks, Liu X*, Wang Y*, Ji H, Aihara K, Chen L, 2016
